Biotech Stocks Reviews
- Findings From a Real-World Obesity Study
Sat, Dec 2
The big news in obesity last week was that Pfizer’sPhase 2b datafor twice-oral danuglipron flopped. · more » - Replay & Transcript of KOL Call: Benefits of AI in Cancer Surgeries
Fri, Dec 1
TRANSCRIPTParticipants Amelia Tower, KOL Adrian Mendes, Perimeter Medical CEO Deniel Mero, PropThink · more » - Contributors to US Excessive Drug Pricing
Sat, Nov 25
Drug pricing in the US is not a straightforward process. For the most part, this is done by design. · more » - Combos Could be Next Paradigm in Obesity Treatments
Thu, Nov 23
With Thanksgiving weekend here, food is atop the mind of all Americans. We thought it only appropriate · more » - Radiopharmaceutical Space Rolling as Eli Lilly Acquires Point
Tue, Oct 3
This morning, Eli Lilly (LLY) acquired Point Bio (PNT) for $12.50/share, an 87% premium. The $1.4B price · more » - Structure (GPCR) Rallies on Oral GLP-1 & Abbott Claims CGM Tech A Companion to GLP
Fri, Sep 29
Structure Therapeutics (GPCR) is up more than 35% this morning after announcing Phase 1b data of its · more » - Transcript Immunovant (IMVT) IMVT-1402 Phase 1 SAD & MAD Results
Wed, Sep 27
Operator Good morning. My name is Michelle, and Im your conference call operator. As a reminder, this · more » - Transcript: Soleno (SLNO) Data of DCCR for Prader-Willi Syndrome
Wed, Sep 27
Operator Greetings. Welcome to Soleno Therapeutics Randomized Withdrawal Period of Study C602 Top Line · more » - Transcript: Cardiff (CRDF) Phase 2 Onvansertib Data in Pancreatic & SCLC
Wed, Sep 27
Operator Welcome to the Cardiff Oncology Clinical Development Update Conference Call. [Operator · more »